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CataractMicroRNA-125b (miR-125b) has been implicated in a variety of diseases as either repressors or promoters, and
plays crucial roles inmany cellular processes such as cell differentiation, proliferation and apoptosis. Age-related
cataract has become one of the most serious problems facing the aging population in the world. The purpose of
this study was to investigate the role of miR-125b in the development of age-related cataract. We demonstrated
that miR-125b was downregulated in both age-related cataract tissue and lens epithelial cell apoptosis induced
by UV irradiation. We also identiﬁed the impact of miR-125b on apoptosis in a lens epithelial cell line. In vitro,
miR-125b regulates human lens epithelial cell apoptosis at least in part by directly targeting p53. In addition,
an inverse relationship betweenmiR-125b and p53 expressionwas seen in age-related cataract tissue. In conclu-
sion, this study suggests that miR-125b might be closely involved in the pathogenesis of cataract, and has the
potential to be a diagnostic biomarker or even a therapeutic modality for cataract.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
With the advancement in economy, health and education, population
aging is becoming increasingly societal burden to mankind. Cataract, one
of the common age-related diseases, remains the leading cause of blind-
ness worldwide [1]. It has been reported that age-related cataracts are
responsible for nearly half of all blindnessworldwide and half of all visual
impairment in the USA [2–4]. A recent Italian epidemiological study has
shown that 96% of people aged over 60 can be foundwith different sever-
ities or forms of lens opacity [5]. It is estimated byWHO that therewill be
40 million people worldwide with cataract blindness by 2025 [6]. Age-
related cataract results in severe visual impairment, lowers quality of
life, and has a signiﬁcant impact on health resources and social economy.icroRNA; UTR, untranslated re-
CR, real-time quantitative poly-
; DMEM, Dulbecco's modiﬁed
feringRNA;GAPDH, glyceralde-
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u), zhangjs0331@126.comChallenges remain in ﬁghting cataract across the world, including
large number of cataract patients, uneven distribution of medical re-
sources, cost of operation, and development of posterior capsular
opaciﬁcation after surgery. As a result, although operation is currently
themost effective cataract therapy, potential beneﬁts warrant exploring
nonoperative treatment of cataract. A poor understanding of the patho-
genesis of cataract has been a hurdle in such a pursuit. Previous evidence
indicated that lens epithelial cell apoptosis appears to be a common
cellular basis for non-congenital cataract development in human and
animals [7]. Therefore, study of lens epithelial cell apoptosis may shed
new light in understanding the mechanism of cataract development
and progression. Knowledge gained about microRNA (miRNA) has pro-
vided new opportunities in studying lens epithelial cell apoptosis.
MiRNAs are a group of endogenous small non-coding RNAs, approx-
imately 20 to 25 nucleotides in length, which regulate gene expression
posttranscriptionally [8,9]. MiRNAs regulate mRNA degradation or
translational interference by binding to a complementary sequence
found in the 3′-untranslated regions (UTR) of target gene mRNAs [10].
In the past decade, more and more studies have demonstrated that
aberrant expression of miRNAs was tightly linked to the pathogenesis
of many age-related disease [11–14], including cataract progression
[15,16]. MiRNA research on the treatment of diseases has also made
new breakthroughs [17–19].
MicroRNA-125b (miR-125b), a highly conservedmiRNA throughout
diverse species from nematode to human, has been implicated in a va-
riety of diseases as either repressors or promoters [20]. MiR-125b
Fig. 1.MiR-125b was downregulated in age-related cataract lens tissue. Downregulated
expression of miR-125b was demonstrated in 56 fresh specimens of anterior lens capsule
of age-related cataract using RT-qPCR (n= 3, mean ± SD, **P b 0.001).
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proliferation and apoptosis by targeting many different transcription
factors [21], matrix-metalloprotease [22,23], and growth factors [24].
However, little is known about the role of miR-125b in the progres-
sion of lens disease, including cataract. This study found, for the ﬁrst
time, the crucial role of miR-125b and its direct target gene p53 in age-
related cataract. We demonstrated that miR-125b was downregulated
in age-related cataract tissue.We further observed thatmiR-125bwas in-
versely related to the level of p53 in age-related cataract tissue. Addition-
ally, we showed that miR-125b regulated human lens epithelial cell
apoptosis at least in part by directly targeting p53.
2. Materials and methods
2.1. Specimens
Fresh specimens of anterior lens capsule of age-related cataractwere
obtained from cataract patients with no other eye diseases during
phacoemulsiﬁcation at the Fourth Afﬁliated Hospital of China Medical
University between September 2012 and August 2014. Normal anterior
lens capsule specimens were obtained from the Eye Bank of the Fourth
Afﬁliated Hospital of ChinaMedical University. This studywas approved
by the hospital's Ethic Committee and conducted with the approval of
the institutional review board at the Fourth Afﬁliated Hospital of
China Medical University. Written informed consent was obtained
from all patients for all clinical investigation conducted.
2.2. Ultraviolet (UV) irradiation of cultured cells
Twin 15 W UVB lamps with a ﬁlter assembly (XX-15B, Spectroline,
Westbury, NY, USA) were used for irradiation; these lamps emit an
energy spectrum of 280–320 nmwith a high ﬂuence in the UVB region
and a maximum emission peak at 312 nm. The intensity and dose
were measured using a UVX Radiometer connected to a UVX-31 Sensor
(calibrationwavelength 312 nm) (bothwere fromUVP Inc., SanGabriel,
CA, USA). Before UV irradiation, cells (1 × 105/well) were washed with
Dulbecco's phosphate buffer saline (PBS) and then changed to 0.5 ml
PBS in each well. Human lens epithelial cells were irradiated without
a plastic dish lid with an intensity of 360 μW/cm2. Time of irradiation
was varied at 5 min, 10 min, 15 min, 20 min, 25 min and 30 min.
After exposure, the PBS was immediately replaced by fresh medium
for a continued incubation of another 4 h.
2.3. Real-time quantitative polymerase chain reaction (RT-qPCR)
Total RNA from fresh tissues and cell lines was extracted using
Trizol® Reagent (Invitrogen, NY, USA) following the manufacturer's in-
structions. The quality of RNA was examined using an UV–Vis spectro-
photometer UV-1800 (Shimadzu, Japan). RNA integrity was veriﬁed
using 1.5% agarose gel electrophoresis with OD260/280 between 1.8
and 2.0, and RNA 28 s/18 s N 1.
RT-qPCR analysis of miR-125b was carried out using RT primer and
TaqMan probe of miR-125b (Ribobio, Guangzhou, China) on an ABI
7500 (Applied Biosystems, USA) according to the manufacturer's
protocol. Expression of RNA U6 small nuclear 2 (RNU6B) was used as
an endogenous reference control. Each RT-qPCR analysis was repeated
twice, using three independent specimens. The relative abundance of
miR-125b in tissues and cell lines was calculated using the equation
RQ= 2−ΔΔCT.
For RT-qPCR analysis of p53, RNA was reverse-transcribed with
PrimerScript RT reagent kit (Takara, Dalian, China). The resulting
cDNA was ampliﬁed using p53 primers with SYBR Premix Ex TaqTM II
(Takara, Dalian, China) with the following parameters 95 °C for 30 s,
followed by 40 cycles at 95 °C for 5 s, and at 60 °C for 30 s. Primers for
p53 were as follows: forward 5′-CAGCAGTCAAGCACTGCCAAG-3′,
reverse 5′-AGACAGGCATGGCACGGATAA-3′. Primers for endogenousβ-actin were: forward 5′-CATCCGTAAAGACCTCTATGCCAAC-3′, reverse
5′-ATGGAGCCACCGATCCACA-3′. In order to ensure product speciﬁcity,
melting curve analysis was performed at the end of the cycles. The rel-
ative quantity of p53, normalized to β-actin, was calculated based on
the equation RQ= 2−ΔΔCT.
2.4. Cell culture and transfection
SV40 T-antigen-transformed human lens epithelial cell line (SRA01/
04 cell) [25] was gifted from Dr. Yi-sin Liu, Doheny Eye Institute, US.
SRA01/04 cells were cultured in Dulbecco's Modiﬁed Eagle's Medium
(DMEM) (Gibco® Invitrogen, Carlsbad, USA) supplemented with 10%
fetal bovine serum (FBS) (Hyclone, Logan, USA), 100 U/ml penicillin,
and 100 U/ml streptomycin. Cells were incubated in a humidiﬁed 37 °C
incubator containing 5% CO2.
SRA01/04 cells were transfected using Lipofectamine 2000
(Invitrogen, USA) according to the manufacturer's protocol. MiR-125b
mimic, mimic negative control, inhibitor and inhibitor negative control
were from RiboBio (Guangzhou, China) and transfected into SRA01/04
cells. The complexes containing the mimic or mimic negative control
were added to cells at a ﬁnal concentration of 50 nM, while the mixture
containing the inhibitor or inhibitor negative control was at a ﬁnal con-
centration of 100 nM. Moreover, small interfering RNA (siRNA) for p53
and a negative control were designed and synthesized by GenePharma
(Shanghai, China) and transfected into SRA01/04 cells. The sequences
of the p53 siRNA were 5′-CUACUUCCUGAAAACAACGTT-3′ (sense),
and 5′-CGUUGUUUUCAG GAAGUAGTT-3′ (antisense). After 48 h, the
expression of miR-125b was detected by RT-qPCR, the expression of
p53 was tested by RT-qPCR and Western blot, and the cell apoptosis
rate was measured by ﬂow cytometry.
2.5. Terminal deoxynucleotidyl transferase deoxy-UTP-nick end labeling
assay (TUNEL assay)
All the anterior lens capsules with adherent lens epithelium cells
were placed in tubes ﬁlled with fortiﬁed balanced salt solution after
being removed out of the eyes. Then anterior capsules were transferred
into 10% neutral-buffered formalin immediately. After ﬁxation, 15
capsules of each groupwere further dehydrated through graded alcohols,
cleared in xylene, and embedded in parafﬁn. And then 4 μmsectionswere
cut for TUNEL ﬂuorescein analysis.
Sections were rehydrated through graded alcohols and the terminal
deoxynucleotidyl transferase deoxy-UTP-nick end labeling (TUNEL)
assay was performed using a standard kit, ﬂuorescein DeadEnd™
Fluorometric TUNEL System (Promega, Madison, WI). The TUNEL
assay detects the ends of DNA fragments formed during the apoptosis
Fig. 2.Apoptosis analysis by TUNEL staining. (A)&(B) TUNEL positive cellswere observed in large amounts in cataract group. (C)&(D) TUNEL positive cellswere rarely found in normal lens
group. (E) The higher cell apoptosis rate was detected in cataract group than normal lens group (n= 60, mean ± SD, **P b 0.001).
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performed using 4′,6-diamidino-2-phenylindole dihydrochloride
(DAPI) in both groups. Then, all tissue sections were covered with aFig. 3. (A) Lens epithelial cell apoptosis induced by UVB irradiation in SRA01/04 cell line. Cells w
540 mJ/cm2. Cell apoptosis rate was approximately 48.90% under this condition. (B) The expre
apoptosis (n= 3, mean ± SD, **P b 0.001).mounting medium. Bright-ﬁeld and ﬂuorescence images of sections
were taken using Olympus microscope (BX51, Olympus) with a SPOT
camera.ere irradiatedwith an intensity of 360 μW/cm2 for 25min to achieve an effective dosage of
ssion of miR-125b as detected by RT-qPCR was downregulated during lens epithelial cell
Fig. 4.Assessing transfection efﬁciency in lens epithelial cell apoptosis induced by UV
irradiation. (A) The expression of miR-125b transfected with miR-125b mimic was
increased. (B) The expression of miR-125b was signiﬁcantly decreased when transfected
with miR-125b inhibitor (n= 3, mean ± SD, **P b 0.001).
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After UV irradiation or 48 h after transfection, SRA01/04 cells
(1–5 × 105/well) were collected and then subjected to an apoptosis
assay. Apoptosiswas determined by annexin V/propidium iodide staining
with the apoptosis detection kit (KenGEN, China). After incubation for
15 min at room temperature in darkness, the specimens were assessed
by ﬂow cytometry (BDBiosciences, CA, USA). Plasmamembrane integrity
was shownon the Y-axis and annexin V immunoﬂuorescencewas shown
on the X-axis. Assays were performed in three independent experiments.
2.7. Western blot
SDS-PAGE andWestern blots were performed according to standard
procedures. Cells were extracted with lysis buffer containing 150 mM
NaCl, 1% NP-40, 0.1% SDS, 2 mg/ml aprotinin and 1 mM PMSF for
30 min at 4 °C. Protein extracts were separated on 10% SDS-PAGE gels
and transferred onto PVDF membranes. After blocking in TBST contain-
ing 25 mmol/l Tris–HCl, pH 7.5, 137 mmol/l NaCl, 2.7 mmol/l KCl and
0.05%Tween20with 5%nonfatmilk for 1 h at 37 °C,membraneswere in-
cubated with primary antibody against p53 (Santa Cruz, CA, USA) or
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Santa Cruz, CA,
USA) in TBST with 5% nonfat milk at 4 °C overnight. Membranes were
extensivelywashed three timeswith TBST and incubatedwith secondary
antibody at room temperature for 1 h. After additionalwasheswith TBST,
proteins were visualized with an ECL kit (Santa Cruz, CA, USA). The in-
tensity of protein bands was quantiﬁed using Image J software (National
institutes of Health, Md, USA).
2.8. Luciferase activity assay
The 3′-UTR of the p53 gene including conserved binding sites for
miR-125b was ampliﬁed from human cDNA. The ampliﬁed fragments
were inserted into the pmiR-RB-REPORT™ vector (Ribobio, Guangzhou,
China). Amutant 3′-UTR fragment, withmutations in seed binding sites,
was generated. Similarly, the fragment of p53-3′-UTR mutant was
inserted into the pmiR-RB-REPORT™ control vector at the same sites.
For reporter assays, SRA01/04 cells were seeded into 24-well plates, cul-
tured overnight, then cotransfected with wild-type (mutant) reporter
plasmid, miR-125b mimic, and mimic control (Ribobio, Guangzhou,
China) using Lipofectamine 2000 (Invitrogen, USA). Luciferase activity
was analyzed 48 h post-transfection using Dual-Luciferase Reporter
Assay System according to the manufacturer's instructions (Promega,
Madison, WI, USA). The Renilla luciferase plasmid was used as an
endogenous control. Each experiment was repeated twice, using three
independent specimens.
2.9. Statistical analysis
All experiments were repeated twice at least. All data were reported
asmean± standard deviation (SD). Differenceswere assessed by an in-
dependent sample t-test. P b 0.05 was considered statistically signiﬁ-
cant. SPSS16.0 statistical software was used for statistical analysis.
3. Results
3.1. MiR-125b was downregulated in anterior lens capsule of age-related
cataract
A total of 56 fresh specimens of anterior lens capsule of age-related
cataract were examined for the expression of miR-125b and compared
with an equal number of normal anterior lens capsule specimens.
Compared with controls, the expression level of miR-125b as detected
by RT-qPCR was signiﬁcantly lower in the anterior lens capsules of
age-related cataract (Fig. 1).3.2. TUNEL positive cell count was higher in anterior lens capsule of
age-related cataract
Apoptotic cells of 15 fresh specimens of anterior lens capsule of age-
related cataract were detected by TUNEL assay and compared with an
equal number of normal anterior lens capsule specimens. TUNEL posi-
tive cells were observed in large amounts in cataract group, while rarely
in normal lens group (Fig. 2A–D). Furthermore, the higher cell apoptosis
rate was detected in cataract group than normal lens group (Fig. 2E).
3.3. Assessment of lens epithelial cell apoptosis induced by UV irradiation
In order to induce lens epithelial cell apoptosis, we used UVB irradi-
ation and the SRA01/04 cell line. According to the preliminary experi-
ment, the UV dosage totally acquired was 540 mJ/cm2 with exposure
duration of 25 min and intensity of 360 μW/cm2. Cell apoptosis rate
was increased by approximately 48.90% under this condition (Fig. 3A).
3.4. MiR-125b was downregulated during lens epithelial cell apoptosis and
hindered apoptosis as induced by UV irradiation in vitro
The expression of miR-125b in lens epithelial cell apoptosis as in-
duced by UV irradiation was detected using RT-qPCR. Lens epithelial
cell apoptosis induced by UV irradiation showed signiﬁcant downregu-
lation ofmiR-125b comparedwith controls (SRA01/04 cell without UVB
irradiation) (Fig. 3B).
Downregulated expression of miR-125b in both tissues and lens ep-
ithelial cell apoptosis induced by UV irradiation suggest that miR-125b
2443Y. Qin et al. / Biochimica et Biophysica Acta 1842 (2014) 2439–2447is implicated in apoptosis. Thus, the next experiment was conducted to
determine the potential effects ofmiR-125b on apoptosis in human lens
epithelial cells. Before UV irradiation, the lens epithelial cell was
transfected with miR-125b mimic, mimic control, inhibitor and inhibitor
control. After 48 h, the expression of miR-125b was examined to identify
transfection effects using RT-qPCR. The relative expression level of
miR-125b in lens epithelial cell apoptosis induced by UV irradiation
transfected with miR-125b mimic was increased (Fig. 4A), whereas
such expression level was signiﬁcantly decreased in cells transfected
with miR-125b inhibitor (Fig. 4B).
As assayed by ﬂow cytometry, the apoptosis rate of cells transfected
with miR-125b mimic was reduced dramatically compared with
controls (Fig. 5A). On the contrary, the apoptosis rate was increased
markedly in the miR-125b inhibitor group (Fig. 5B).
3.5. MiR-125b targets p53
Three different target prediction software were used to predict po-
tential target genes of miR-125b in SRA01/04 cells: TargetScan 5.2,
Diana-microT and miRanda. Among the target gene list, we selected
p53 which has three predicted binding sites with miR-125b for further
analysis due to its important role in regulating cell proliferation [26]
and apoptosis in response to DNA injury [27,28].
To determine whether miR-125b targets p53 in tissue specimens
of anterior lens capsule of age-related cataract, 54 fresh anterior lens
capsules of age-related cataract were selected with an equal numberFig. 5. The effect ofmiR-125b on apoptosis in lens epithelial cells. (A) Cell apoptosis rate as assay
apoptosis rate was increased markedly in the miR-125b inhibitor group (n= 3, mean ± SD, **of normal anterior lens capsule specimens. The expression level of
p53 mRNA and protein was determined using RT-qPCR and western
blot. Both p53mRNAandproteinwere remarkably higher in anterior lens
capsules of age-related cataract (Fig. 6A and B), in contrast to a lower
miR-125b level in the same tissue specimens (Fig. 1), demonstrating a re-
ciprocal relationship between miR-125b and p53 expression.
To determinewhether p53 is regulated bymiR-125b, we transfected
lens epithelial cell apoptosis in vitro with miR-125b mimic, mimic
control, miR-125b inhibitor and inhibitor control before UV irradiation.
At 48 h post transfection, RT-qPCR was performed to assess the mRNA
expression level of p53. Overexpression of miR-125b led to a remark-
able decrease in p53 mRNA compared with controls, while inhibition
of miR-125b increased the level of p53 mRNA (Fig. 7A and B). As deter-
mined by western blot, high expression of miR-125b signiﬁcantly
decreased p53 protein compared with controls, whereas reduction of
miR-125b resulted in an increase of p53 protein (Fig. 7C and D). These
results suggested that the expression of p53 was regulated at both
mRNA and protein levels by miR-125b in vitro.
To conﬁrm if p53 is a direct target of miR-125b, luciferase activity
assays were performed. The p53-3′-UTR was cloned into a luciferase
reporter plasmid, and the luciferase reporter plasmid pmiR-RB-
REPORT™-p53-3′-UTR or a mutant reporter plasmid carrying point
mutations in the presumed miR-125b binding sites (pmiR-RB-
REPORT™-mut-p53-3′-UTR) was co-transfected with miR-125b
mimics. Then the luciferase activity at 48 h post transfection was exam-
ined. The luciferase activity was suppressed by approximately half ined by ﬂowcytometry transfectedwithmiR-125bmimicwas reduced dramatically. (B) Cell
P b 0.001).
Fig. 6. P53 was upregulated in anterior lens capsule of age-related cataract. (A) Upregulated
level of p53 mRNAwas detected using RT-qPCR. (B) The expression of p53 protein detected
by western blot was upregulated (n= 3, mean ± SD, **P b 0.001).
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p53-3′-UTR compared with controls (Fig. 8). Nevertheless, no obvious
suppression was observed when the reporter plasmid carried a mutant
p53-3′-UTR (Fig. 8). These results indicated that miR-125b bound to
p53 3′-UTR region directly and suppressed p53 expression.
To further conﬁrm if miR-125b regulates cell apoptosis by targeting
p53, the cell apoptosis rate was assessed whenmiR-125b and p53were
knocked down simultaneously usingmiR-125b inhibitor and p53 siRNA
respectively. Before UV irradiation, the lens epithelial cell was co-
transfected with the following combinations: (a) siRNA normal control
(NC)/miRNA inhibitor NC; (b) miR-125b inhibitor/siRNA NC; (c) p53
siRNA/miR-125b inhibitor; and (d) p53 siRNA/miRNA inhibitor NC.
Forty-eight hours after transfection, we measured p53 protein expres-
sion using western blot and cell apoptosis rate by ﬂow cytometry. As
shown in Fig. 9A, the expression of p53 protein increased in cells co-transfected with (b) miR-125b inhibitor/siRNA NC, and markedly
decreased in cells co-transfected with (d) p53 siRNA/miRNA inhibitor
NC. In cells co-transfected with (c) p53 siRNA/miR-125b inhibitor,
the expression of p53 showed little change compared with cells co-
transfected with (a) siRNA NC/miRNA inhibitor NC. Moreover, cell
apoptosis rates showed good correlation with the level of p53 protein
expression (Fig. 9B). Taken together, these results proved that co-
transfection of miR-125b inhibitor and p53 siRNA inhibited the effect
of miR-125b on cell apoptosis and miR-125b was vital in the regulation
of cell apoptosis by directly targeting p53.
4. Discussion
MiRNAs are known to be key players in the regulation of transcripts
involved in processes as diverse as embryonic development, differenti-
ation, cellular proliferation, apoptosis, metabolism and adaptation to
environmental stress [10]. Over one third of human genes appear to
be conserved miRNA targets [29]. Most diseases were found to have
changes inmiRNA expression proﬁle. Mutations ofmiRNA and its target
genes have been reported to cause a variety of diseases. Given the in-
volvement of miRNA regulation in multiple cellular processes, it is not
surprising that this process plays a part in complex, multifactorial and
environmentally-inﬂuenced cellular processes such as human disease
and cellular and organismal ageing [30].
Research of miRNAs in Ophthalmology is just at its early stage. Ryan
et al. [31] demonstrated that there were more than 30 miRNAs
expressed in cornea and 17 in lens of adult mouse. MiR-184 had the
highest hybridization signal in the corneal and lens arrays. Frederikse
et al. [32] provided evidence that miRNAs and Dicer were expressed in
mammalian lenses. Hughes et al. [15] found that mutation in the seed
region of miR-184 caused anterior polar cataract. Peng et al. [16] dem-
onstrated that let-7 expression was signiﬁcantly related to the severity
of lens opacity and age of age-related cataract. Xu et al. [33] found that
at least 78 miRNAs were expressed in adult mouse retina, some of
which were associated with retinal development, circadian rhythm
(miR-183), retinal pigment degeneration (miR-1, miR-133, miR-183),
andmacular degeneration (miR-31, miR-150).Wu et al. [34] investigat-
ed miRNA expression proﬁles in human lens samples and found several
differences between the expression proﬁles of transparent and catarac-
tous lenses. The top eight differentially expressed miRNAs included
miR-184, let-7b, miR-923, miR-1826, miR-125b, miR-1308, miR-26a,
and miR-638 in transparent samples, and miR-184, miR-1826, let-7b/c,
miR-24, miR-23b, miR-923, and miR-23a in cataractous lenses.
As a newly recognized mechanism of gene expression regulation, the
contributions of miRNAs to disease pathogenesis and clinical therapy of
lens disease have not been well studied. To date, research in this area
was limited to the detection of miRNA expression. No investigation of
miRNAs has been published regarding regulation.
The present study identiﬁed, for theﬁrst time, the impact ofmiR-125b
on age-related cataract.
UVR was shown to induce the apoptosis of lens epithelial cells,
which was considered to be a common cellular pathway for non-
congenital cataract development [35]. P53 gene was closely associated
with the lens epithelial cell apoptosis [36]. In the lens, the increased
p53 expression could be responsible for apoptosis induced by UVR
[37]. Recent studies conﬁrmed thatmiRNAs and p53 can form a compli-
cated multi-level regulatory network [38].
Li et al. [7] indicated that cataract patients may have deﬁcient
defense systems against factors such as oxidative stress and UV at the
onset of the disease. Such stress could trigger lens epithelial cell apopto-
sis that thenmight initiate cataract development. In their study, all of the
cataract patients examined had a substantial percentage of apoptotic
lens epithelial cells while normal human lenses of comparable age had
very few such cells. Their observations suggested that lens epithelial
cell apoptosismay be an early and critical event during cataract develop-
ment, and a common cellular basis for initiation of noncongenital
Fig. 7. The effect of miR-125b on p53 in lens epithelial cell apoptosis induced by UV irradiation. (A)&(B) Overexpression of miR-125b led to a marked decrease in p53 mRNA level, while
inhibition of miR-125b increased the level of p53mRNA. (C)&(D) High expression ofmiR-125b resulted in signiﬁcant decrease of p53 protein, whereas reduction of miR-125b resulted in
an increase of p53 protein (n= 3, mean ± SD, **P b 0.001).
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chromatic radiation at 297 nm was more than 6, 590, 1400 and 3000
times as effective in cell killing as 302, 325, 334 and 365 nm radiation,Fig. 8. P53was a direct target of miR-125b in lens epithelial cell. MiR-125b binding sites in
the 3′-UTR of p53 was assessed using luciferase activity assay. The luciferase activity was
suppressed by approximately half in cells transfectedwith the reporter plasmid carrying the
wild type p53-3′-UTR. No obvious suppression was observed when the reporter plasmid
carried a mutant p53-3′-UTR (n= 3, mean ± SD, **P b 0.001).respectively [39]. UVB (280–320 nm) exposure is considered an impor-
tant risk factor for cataract [40]. Consequently, we used UVB irradiation
to induce SRA01/04 cell apoptosis.
Currently, research onmiR-125b ismostly concentrated in the ﬁeld of
cancer research. MiR-125b has high expression in certain tissues while
low expression in others, indicating its relative tissue speciﬁcity. It is
important to know that the same target may have different functions in
different cellular processes, cellular context, and diseases. Therefore,
targeting genes of speciﬁc cell-type may be useful as a more precise
and speciﬁc therapy using miRNAs [20]. Zeng et al. [41] found that
miR-125b modulated apoptosis in cancer cells by targeting p53. In our
study, p53 was predicted as a potential target of miR-125b by three
different target prediction software and subsequently conﬁrmed by
luciferase assay, for the ﬁrst time, in SRA01/04 cells.
MiR-125b downregulation in age-related cataract lens tissues is also
a novel ﬁnding. In addition, we demonstrated an inverse correlation
between miR-125b and p53, consistent with the hypothesis that p53
is a target of miR-125b.
Using the human lens epithelial cell line (SRA01/04 cell) as an
in vitro model, we found that miR-125b was downregulated during
lens epithelial cell apoptosis. The involvement of miR-125b in apoptosis
Fig. 9.MiR-125b regulated lens epithelial cell apoptosis by targeting p53. (A)&(B) The expression of p53 protein increased in cells co-transfected with (b) miR-125b inhibitor/siRNA NC,
andmarkedly decreased in cells co-transfectedwith (d) p53 siRNA/miRNA inhibitor NC. In cells co-transfectedwith (c) p53 siRNA/miR-125b inhibitor, the expression of p53 showed little
change compared with cells co-transfected with (a) siRNA NC/miRNA inhibitor NC. Cell apoptosis rates correlated well with the level of p53 protein expression (n = 3, mean ± SD,
**P b 0.001).
2446 Y. Qin et al. / Biochimica et Biophysica Acta 1842 (2014) 2439–2447was conﬁrmed by ﬂow cytometry study, indicating that miR-125b is a
suppressor of cell apoptosis. Moreover, we identiﬁed that p53 was a
direct target, at least in part, ofmiR-125b in SRA01/04 cells by luciferase
activity assay. All the data above suggested that miR-125b played a
crucial role in cataract progression, and had the potential as a diagnostic
and therapeutic tool of cataract.
Currently, a growing body of research elucidated that miRNA can be
used as biomarkers for cancers and other diseases, depending on their
abundance [20]. One milestone study [17] demonstrated the efﬁcacy
of a miR-26a-based therapy for liver cancer. Another important study
[18] reported that therapeutic silencing of miR-122 played a crucial
role in primates with chronic hepatitis C virus infection. Rayner et al.
[19] showed that pharmacological inhibition of miR-33a and b was a
promising therapeutic strategy to raise plasma HDL and lower VLDL
triglycerides for the treatment of dyslipidemia. Intraocular injection of
pre-miR-31, -150, or -184 signiﬁcantly reduced ischemia-induced
retinal neovascularization, and injection of pre-miR-31 or -150 also
signiﬁcantly reduced choroidal neovascularization, suggesting that
alteration of miRNA levels contributes to two types of ocular neovascu-
larization, and that injection or enhanced expression of miRNAs has the
potential as a therapeutic strategy [42].
What is more, ongoing studies demonstrate the advantages using
miR-125b as diagnostic and prognostic biomarkers. For example, miR-
125b regulatedMcl-1 and IL6R, andwas downregulated in hepatocellu-
lar carcinoma, conﬁrming the tumor suppressive role of miR-125b in
hepatocellular carcinoma and the potential usefulness of miR-125b in
miRNA-based cancer therapy [43]. MiR-125b was signiﬁcantly
overexpressed in thyroid cancer and its level varies drastically between
benign and malignant thyroid tissue specimens [44]. MiR-125b was
directly involved in cancer progression and associated with poor prog-
nosis in human colorectal cancer, suggesting that miR-125b could be
an important prognostic indicator for colorectal cancer patients [45].
But unfortunately, little investigation of miRNA-based therapy for
senescence disease has been reported at present.
In conclusion, miR-125b, a dramatically downregulated miRNA in
age-related cataract lens tissue, plays a critical role in regulating
human lens epithelial cell apoptosis at least in part by targeting p53.
An upregulation of miR-125b may down regulate p53 and protect lens
epithelial cells during cataract formation. Although further studies arerequired to elucidate the exact molecular mechanisms, it is certain
that miR-125b is closely involved in the pathogenesis of cataract. The
present study provides new insights into a potential diagnostic bio-
marker or even a therapeutic modality for cataract.
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